Question 1

What is the catalog number for Human TBC1D2B Knockout A549 cell line?

Accepted Answer

The catalog number for Human TBC1D2B Knockout A549 cell line is A549KO-19163.

Question 2

What sizes are available for Human TBC1D2B Knockout A549 cell line?

Accepted Answer

Human TBC1D2B Knockout A549 cell line is available in the following size(s): 1 Vial.

Question 3

Is Human TBC1D2B Knockout A549 cell line in stock?

Accepted Answer

Human TBC1D2B Knockout A549 cell line is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is Human TBC1D2B Knockout A549 cell line used for?

Accepted Answer

Engineered clonal A549 cells with TBC1D2B gene knockout, sequence confirmed.

Question 5

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 6

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 7

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Human TBC1D2B Knockout A549 cell line

Product Specifications

Frequently Asked Questions

Explore Other Products

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2743), CF594 conjugate, 0.1mg/mL

5,6-Diamino-2,4-dihydroxypyrimidine-13C2, Hydrochloride Salt

2-Hydroxychrysene

Phospho-Pan-Akt (Ser473) Polyclonal Antibody

Phospho-Pan-Akt (Ser473) Polyclonal Antibody

Phospho-Pan-Akt (Ser473) Polyclonal Antibody